---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-200857"
form_type: "8-K"
ticker: "BDSX"
cik: "0001439725"
company_name: "BIODESIX INC"
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T08:59:26.118834+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Biodesix posts updated corporate presentation with no new financial or operational data

## Summary
- Presentation filed under Item 7.01 and available on IR website.
- Company describes itself as a blood-based lung diagnostic firm addressing large unmet need.
- No specific financial figures, guidance, or clinical updates were disclosed.
- Presentation contains no material new information beyond general business description.

## SEC filing metadata
- accession: 0001193125-24-200857
- form_type: 8-K
- ticker: BDSX
- cik: 0001439725
- company_name: BIODESIX INC
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439725/000119312524200857/0001193125-24-200857-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439725/000119312524200857/d881327d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-200857
- JSON: https://secwatch.observer/filing/0001193125-24-200857.json
- Plain text: https://secwatch.observer/filing/0001193125-24-200857.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.